PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Insulet Corporation (PODD) recently made its Omnipod 5 Automated Insulin Delivery (“AID”) system commercially available in Canada for people with type 1 diabetes (ages two years and above). Omnipod 5 is available with Dexcom G6 and G7 continuous glucose monitoring (“CGM”) sensor compatibility. The latest development represents a significant step forward in expanding access to its innovative, tubeless Omnipod 5 AID system for more people globally. PODD Stock’s Likely Trend Following the NewsFollowing the ann ...